Lukas Käsmann

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 9

Top Topics

Small Cell Lung Cancer

Systematic Review

St Segment Elevation Myocardial Infarction

Radiation Therapy

Top Venues

Radiation oncology (London, England)

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Julian Taugner, Lukas Käsmann, Monika Karin, Chukwuka Eze, Benedikt Flörsch, Julian Guggenberger, Minglun Li, Amanda Tufman, Niels Reinmuth, Thomas Duell, Claus Belka, Farkhad Manapov
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition. Investigational new drugs (2021)
Julian Taugner, Lukas Käsmann, Chukwuka Eze, Alexander Rühle, Amanda Tufman, Niels Reinmuth, Thomas Duell, Claus Belka, Farkhad Manapov
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients. Investigational new drugs 39 (4) (2021)
Lukas Käsmann, Alexander Dietrich, Claudia A Staab-Weijnitz, Farkhad Manapov, Jürgen Behr, Andreas Rimner, Branislav Jeremic, Suresh Senan, Dirk De Ruysscher, Kirsten Lauber, Claus Belka
Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review. Radiation oncology (London, England) 15 (1) (2020)
Lukas Käsmann, Chukwuka Eze, Julian Taugner, Farkhad Manapov
In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer. Radiation oncology (London, England) 15 (1) (2020)
Lukas Käsmann, Annemarie Schröder, Benjamin Frey, Daniel F Fleischmann, Tobias Gauer, Nadja Ebert, Markus Hecht, David Krug, Maximilian Niyazi, Matthias Mäurer, null null
Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 197 (8) (2020)
Kathrin Gennen, Lukas Käsmann, Julian Taugner, Chukwuka Eze, Monika Karin, Olarn Roengvoraphoj, Jens Neumann, Amanda Tufman, Michael Orth, Simone Reu, Claus Belka, Farkhad Manapov
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. Radiation oncology (London, England) 15 (1) (2020)
Lukas Käsmann, Reem Abdo, Chukwuka Eze, Maurice Dantes, Julian Taugner, Kathrin Gennen, Olarn Roengvoraphoj, Dirk Rades, Claus Belka, Farkhad Manapov
External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy. Lung 198 (1) (2020)
Maurice Dantes, Lukas Käsmann, Olarn Roengvoraphoj, Farkhad Manapov, Chukwuka Eze
Adjuvant radiotherapy additionally to chemotherapy in resected node-positive small cell lung cancer: A role assessment without randomized evidence. The clinical respiratory journal 14 (5) (2020)
Dmytro Oliinyk, Teresa Augustin, Viktoria Florentine Koehler, Josefine Rauch, Claus Belka, Christine Spitzweg, Lukas Käsmann
Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis. Cancers 12 (9) (2020)